2020-06-11 |
2020-06-09 |
B
Purchase
|
COLA MICHAEL F
Chief Executive Officer
Executive Director
|
100,000
+132.0%
2.50
USD 250,000
|
100,000
+132.0%
|
2.50
|
USD 250,000
|
|
2020-02-07 |
2019-12-19 |
B
Purchase
|
ASTRAZENECA PLC
Large shareholder
|
12,946,900
0.00
USD 0
|
12,946,900
|
0.00
|
USD 0
|
|
2019-12-09 |
2019-12-05 |
S
Sale
|
BARER SOL J
Non-Executive Director
|
4,098,752
-100.0%
0.13
USD 549,233
|
4,098,752
-100.0%
|
0.13
|
USD 549,233
|
|
2019-12-09 |
2019-12-05 |
B
Purchase
|
COLA MICHAEL F
President and CEO
Executive Director
|
2,049,376
+938.0%
0.13
USD 274,616
|
2,049,376
+938.0%
|
0.13
|
USD 274,616
|
|
2019-12-09 |
2019-12-05 |
B
Purchase
|
NEIL GARRY ARTHUR
Chief Scientific Officer
Officer
|
2,049,376
+1785.6%
0.13
USD 274,616
|
2,049,376
+1785.6%
|
0.13
|
USD 274,616
|
|
2018-11-13 |
2018-11-07 |
B
Purchase
|
GRANO JOSEPH J JR
Non-Executive Director
|
21,000
+58.7%
1.15
USD 24,150
|
21,000
+58.7%
|
1.15
|
USD 24,150
|
|
2018-11-13 |
2018-11-07 |
B
Purchase
|
GRANO JOSEPH J JR
Non-Executive Director
|
21,000
+350.0%
1.17
USD 24,570
|
21,000
+350.0%
|
1.17
|
USD 24,570
|
|
2018-11-13 |
2018-11-07 |
B
Purchase
|
GRANO JOSEPH J JR
Non-Executive Director
|
26,000
+52.3%
1.16
USD 30,212
|
26,000
+52.3%
|
1.16
|
USD 30,212
|
|
2018-08-17 |
2018-08-15 |
B
Purchase
|
Children's Hospital of Philadelphia Foundation
Large shareholder
|
2,551,020
+16.1%
0.96
USD 2,448,979
|
2,551,020
+16.1%
|
0.96
|
USD 2,448,979
|
|
2018-08-17 |
2018-08-15 |
B
Purchase
|
BARER SOL J
Non-Executive Director
|
2,551,020
+inf%
0.96
USD 2,448,979
|
2,551,020
+inf%
|
0.96
|
USD 2,448,979
|
|
2017-10-18 |
2017-10-17 |
B
Purchase
|
BAUER EUGENE A
|
19,841
+13.6%
1.26
USD 25,000
|
19,841
+13.6%
|
1.26
|
USD 25,000
|
|
2017-10-18 |
2017-10-17 |
B
Purchase
|
GANTZ WILBUR H
|
39,683
+126.4%
1.26
USD 50,001
|
39,683
+126.4%
|
1.26
|
USD 50,001
|
|
2017-10-18 |
2017-10-17 |
B
Purchase
|
BARER SOL J
|
421,032
+69.4%
1.26
USD 530,500
|
421,032
+69.4%
|
1.26
|
USD 530,500
|
|
2017-10-18 |
2017-10-17 |
B
Purchase
|
COLA MICHAEL F
President and CEO
Executive Director
|
119,047
+119.7%
1.26
USD 149,999
|
119,047
+119.7%
|
1.26
|
USD 149,999
|
|
2017-10-18 |
2017-10-17 |
B
Purchase
|
Duncan Barbara Gayle
|
59,524
+inf%
1.26
USD 75,000
|
59,524
+inf%
|
1.26
|
USD 75,000
|
|
2017-10-18 |
2017-10-17 |
B
Purchase
|
NEIL GARRY ARTHUR
Chief Scientific Officer
|
75,000
+188.6%
1.26
USD 94,500
|
75,000
+188.6%
|
1.26
|
USD 94,500
|
|
2017-10-18 |
2017-10-17 |
B
Purchase
|
CLEMOW ALASTAIR J
|
19,841
+52.6%
1.26
USD 25,000
|
19,841
+52.6%
|
1.26
|
USD 25,000
|
|
2017-09-06 |
2017-09-01 |
B
Purchase
|
HARPER PHILIP R
Large shareholder
|
83,775
+1.7%
1.20
USD 100,530
|
83,775
+1.7%
|
1.20
|
USD 100,530
|
|
2017-08-24 |
2017-08-23 |
B
Purchase
|
HARPER PHILIP R
Large shareholder
|
5,700
+0.1%
1.20
USD 6,840
|
5,700
+0.1%
|
1.20
|
USD 6,840
|
|
2017-08-24 |
2017-08-22 |
B
Purchase
|
HARPER PHILIP R
Large shareholder
|
4,661
+0.1%
1.20
USD 5,593
|
4,661
+0.1%
|
1.20
|
USD 5,593
|
|